Glaxo Wellcome Inc.

Glaxo Group Limited

Jesus Chicharro Gonzalo

Jose Maria Bueno Calderon

M Pilar Manzano Chinchon

Jose Maria Fiandor

Sophie Huss

Jose M Bueno

Michael John Dawson

Araceli Mallo

Juan Carlos Cuevas

Jose R Gomez

Silvestre Garcia-Ochoa Dorado

Jose Fiandor Roman

Jose-Miguel Coteron

Michael V Hayes

Federico Gomez De Las Heras

Howard G Wildman

Richard M Hall

Brian Arthur Michael Rudd

Milagros Lorenzo Garcia

Jose J Martin

4-pyridone (4-pyridinone) derivatives of Formula I and pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical formulations thereof and their use in chemotherapy of certain parasitic infections such as malaria, are provided.

Heterocyclic compounds

3-Chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H)-pyridinone, having the following formula: is described along with its pharmaceutically acceptable salts, processes for its preparation, pharmaceutical formulations thereof and its uses in treatment of certain parasitic infections such as malaria.

Morpholino ethers

A process for preparing compounds of the formula:

Process for the preparation of indacene compound

Antifungal sordaridin derivatives

Growing community of inventors

Madrid, Spain

Jesus Chicharro Gonzalo